Robotic IVC Thrombectomy Appears Successful in Patients With Kidney Cancer

the ONA take:

According to an article published in The Journal of Urology, a team of surgeons have successfully performed an inferior vena cava (IVC) thrombectomy robotically in nine patients with kidney cancer who developed a level III thrombus. The robotic surgery only requires seven small incisions and four robotic tools.

This procedure is typically complicated and requires a large open incision to remove the difficult-to-reach thrombus that can make its way back to the heart and result in serious harm if not removed. The surgery not only involves the removal of the thrombus but the cancerous kidney as well.

"Level III IVC tumor thrombectomy for renal cancer is one of the most challenging open urologic oncologic surgeries," explained Inderbir S. Gill, MD, of the USC Institute of Urology, part of Keck Medicine of USC in Los Angeles, CA.

The authors found that after approximately 7 months of follow-up, all were alive and eight patients showed no evidence of disease.

"While IVC tumor thrombus occurs in only 4-10% of all patients with otherwise organ-confined kidney cancer, surgery is the only cure. The ability to do this complicated procedure in a minimally invasive way represents a major advancement."

Robotic IVC thrombectomy appears successful in patients with kidney cancer
Surgeons successfully performed an inferior vena cava (IVC) thrombectomy robotically in nine patients with kidney cancer.
Surgery is required when cancer of the kidney causes a Level III thrombus, or clot, to develop in the major vein leading back to the heart. Traditionally this complicated procedure, inferior vena cava (IVC) thrombectomy, is performed using a large open incision, primarily because the vein is often difficult to reach.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs